ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE4608.60-40.15 (-0.86 %)
PREV CLOSE ( ) 4648.75
OPEN PRICE ( ) 4650.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2813
TODAY'S LOW / HIGH ( )4569.15 4650.00
52 WK LOW / HIGH ( )3211.05 5519.1
NSE4616.35-34.5 (-0.74 %)
PREV CLOSE( ) 4650.85
OPEN PRICE ( ) 4625.00
BID PRICE (QTY) 4616.35 (8)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 94277
TODAY'S LOW / HIGH( ) 4567.05 4644.95
52 WK LOW / HIGH ( )3186.3 5520

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.